OIG Sends a Special Fraud Alert on Speaker Programs
C&M Health Law
NOVEMBER 25, 2020
OIG defined speaker programs as drug or device “company-sponsored events at which a [outside] physician or other health care professional (collectively, “HCP”) makes a speech or presentation to other [outside] HCPs about a drug or device product or a disease state on behalf of the company” using a presentation developed and approved by the company.
Let's personalize your content